Tonix Pharmaceuticals, Inc.
Clinical trials sponsored by Tonix Pharmaceuticals, Inc., explained in plain language.
-
Healthy volunteers test muscle relaxant absorption in asian populations
Knowledge-focused CompletedThis study looked at how healthy Japanese and Chinese adults process two different doses of TNX-102 SL, a sublingual (under the tongue) tablet containing cyclobenzaprine, a muscle relaxant. Twenty participants took single doses of 2.8 mg and 5.6 mg on separate days, and researche…
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 07:51 UTC
-
New drug TNX-1500 tested in healthy people for first time
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called TNX-1500 in 26 healthy adults. Participants received either a single dose of the drug or a placebo, and researchers monitored side effects and how the drug moved through the body. The goal was not to treat any disease,…
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC